TNFSF10 and cholangiocarcinoma: In-vitro and in-vivo studies have identified that myofibroblast-derived PDGFbb is potentially cytoprotective to cholangiocarcinoma cells by inhibition of the TRAIL (death ligand) cytotoxicity.37